Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 4, 2011, Pages 619-625

  Olliaro, Piero ^a,j,k   Djimdé, Abdoulaye ^b,j,k   Dorsey, Grant ^c,j,k   Karema, Corine ^d,j,k   Mårtensson, Andreas ^e,j,k   Ndiaye, Jean Louis ^f,j,k   Sirima, Sodiomon B ^g,j,k   Vaillant, Michel ^h,j,k   Zwang, Julien ^i,j,k  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF BAMAKO   (Mali)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d National Malaria Control Program   (Rwanda)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^g MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^h Retrovirology Laboratory   (Luxembourg)

ⁱ Drugs for Neglected Diseases Initiative   (Switzerland)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; AMODIAQUINE PLUS PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE PLUS SULFADOXINE PLUS PYRIMETHAMINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; HEMOGLOBIN; QUININE PLUS CLINDAMYCIN; UNCLASSIFIED DRUG;

AFRICA; ARTICLE; CHILD; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFANT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NEUTROPENIA; NEUTROPHIL COUNT; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; THROMBOCYTE;

AFRICA SOUTH OF THE SAHARA; CHILD; HUMANS; MALARIA, FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 80053903305     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0154     Document Type: Article

References (23)

1. Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ, 2008. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J 7: 127.
2. Tangpukdee N, Yew HS, Krudsood S, Punyapradit N, Somwong W, Looareesuwan S, Kano S, Wilairatana P, 2008. Dynamic changes in white blood cell counts in uncomplicated Plasmodium falciparum and P. vivax malaria. Parasitol Int 57: 490-494.
3. Erhart LM, Yingyuen K, Chuanak N, Buathong N, Laoboonchai A, Miller RS, Meshnick SR, Gasser RA Jr, Wongsrichanalai C, 2004. Hematologic and clinical indices of malaria in a semiimmune population of western Thailand. Am J Trop Med Hyg 70: 8-14. (Pubitemid 39220509)
4. Taylor WR, Widjaja H, Basri H, Ohrt C, Taufik T, Tjitra E, Baso S, Fryauff D, Hoffman SL, Richie TL, 2008. Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria. Malar J 7: 259.
5. Tan SO, McGready R, Zwang J, Pimanpanarak M, Sriprawat K, Thwai KL, Moo Y, Ashley EA, Edwards B, Singhasivanon P, White NJ, Nosten F, 2008. Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border. Malar J 7: 209.
6. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR, 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial. Lancet 359: 1365-1372. (Pubitemid 34442375)
7. Djimdé AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK, 2008. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. Am J Trop Med Hyg 78: 455-461. (Pubitemid 351845197)
8. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ, 2007. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 297: 2210-2219.
9. Karema C, Fanello CI, van Overmeir C, van Geertruyden JP, van Doren W, Ngamije D, D'Alessandro U, 2006. Safety and efficacy of dihydroartemisinin/ piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg 100: 1105-1111. (Pubitemid 44464010)
10. Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Björkman A, 2005. Efficacy of artesunate plus amodiaquine versus that of artemetherlumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis 41: 1079-1086. (Pubitemid 41429468)
11. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Niawanlou Dara YD, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O, 2009. Randomized, multi-centre assessment of the efficacy and safety of ASAQ - a fixeddose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J 8: 125.
12. Sirima SB, Tiono AB, Gansane A, Diarra A, Ouedraogo A, Konate AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR, 2009. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J 8: 48.
13. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M, 2009. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J 8: 203.
14. Olliaro P, Djimdé A, Karema C, Mårtensson A, Ndiaye JL, Sirima SB, Dorsey G, Zwang J, 2011. Estimated versus actual parasitaemia in acute uncomplicated Plasmodium falciparum malaria in African children under five. Trop Med Int Health 16: 551-554.
15. Breusch TS, Pagan AR, 1980. The Lagrange multiplier test and its applications to model specification in econometrics. Rev Econ Stud 47: 239-253.
16. NIAID, 2007. Division of Microbiology and Infectious Diseases Pediatric Toxicity Tables. Available at : http://www.niaid.nih.gov. Accessed June 23, 2010.
17. McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA Jr, Wongsrichanalai C, 2005. White blood cell counts and malaria. J Infect Dis 192: 323-330. (Pubitemid 40993403)
18. Quintó L, Aponte JJ, Sacarlal J, Espasa M, Aide P, Mandomando I, Guinovart C, Macete E, Navia MM, Thompson R, Menéndez C, Alonso PL, 2006. Haematological and biochemical indices in young African children: in search of reference intervals. Trop Med Int Health 11: 1741-1748. (Pubitemid 44624378)
19. Jadhav UM, Singhvi R, Shah R, 2003. Prognostic implications of white cell differential count and white cell morphology in malaria. J Postgrad Med 49: 218-220. (Pubitemid 37493412)
20. Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton CR, 2002. Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol 119: 839-847. (Pubitemid 35366233)
21. Sowunmi A, Akindele JA, Balogun MA, 1995. Leukocyte counts in falciparum malaria in African children from an endemic area. Afr J Med Sci 24: 145-149.
22. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G, 2008. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis 46: 985-991. (Pubitemid 351589861)
23. Dorsey G, Gasasira AF, Machekano R, Kamya MR, Staedke SG, Hubbard A, 2004. The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. Am J Trop Med Hyg 71: 531-536. (Pubitemid 39601145)